洞察市场格局
解锁药品研发情报

客服电话

400-9696-311
医药数据查询

【ChiCTR2600125772】Fractional Radiofrequency Microneedling Combined With Low-Dose Isotretinoin Versus Standard-Dose Isotretinoin in Moderate-to-Severe Acne A Randomized Controlled Pilot Study

基本信息
登记号

ChiCTR2600125772

试验状态

尚未开始

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2026-05-31

临床申请受理号

/

靶点

/

适应症

Acne

试验通俗题目

Fractional Radiofrequency Microneedling Combined With Low-Dose Isotretinoin Versus Standard-Dose Isotretinoin in Moderate-to-Severe Acne A Randomized Controlled Pilot Study

试验专业题目

Fractional Radiofrequency Microneedling Combined With Low-Dose Isotretinoin Versus Standard-Dose Isotretinoin in Moderate-to-Severe Acne A Randomized Controlled Pilot StudyFractional Radiofrequency Microneedling Combined With Low-Dose Isotretinoin Versus Standard-Dose Isotretinoin in Moderate-to-Severe Acne A Randomized Controlled Pilot Study

申办单位信息
申请人联系人
请登录查看
申请人名称
请登录查看
联系人邮箱
请登录查看
联系人邮编

41002

联系人通讯地址
请登录查看
临床试验信息
试验目的

To compare the efficacy of fractional RF microneedling combined with low-dose isotretinoin versus standard-dose isotretinoin monotherapy. To evaluate the safety of RF microneedling during concurrent isotretinoin therapy. To assess the impact of body mass index on treatment response. To examine the influence of lifestyle-related confounders on clinical outcomes

试验分类
请登录查看
试验类型

随机平行对照

试验分期

其它

随机化

Randomization was done by a computer-generated permuted block randomization method (block size = 6).The research team used sealed envelopes, which they had prepared in sequential order, to conduct 1:1 patient randomization between the two treatment groups

盲法

None

试验项目经费来源

None

试验范围

/

目标入组人数

20

实际入组人数

/

第一例入组时间

2026-05-30

试验终止时间

2027-05-01

是否属于一致性

/

入选标准

The study included patients aged 18 to 33 years with moderate-to-severe acne vulgaris of the face, as defined by an Investigator Global Assessment (IGA) score of 3 or 4. All patients had failed or were unsuitable for conventional topical therapy alone. The study included patients aged 18 to 33 years with moderate-to-severe acne vulgaris of the face, as defined by an Investigator Global Assessment (IGA) score of 3 or 4. All patients had failed or were unsuitable for conventional topical therapy alone.;

排除标准

Patients were excluded from the study when they met any of these criteria: 1.They had used isotretinoin during the last 12 months; 2.They had documented hypersensitivity to retinoids; 3.They were currently suffering from active hepatic or renal or metabolic diseases; 4.Females were pregnant or they refused to follow birth control rules; 5.They had an existing skin infection at the sites where RF treatment was scheduled; 6.They had received RF microneedling treatment within the 6 months before their enrollment date.;

研究者信息
研究负责人姓名
请登录查看
试验机构

University of Mosul

研究负责人电话
请登录查看
研究负责人邮箱
请登录查看
研究负责人邮编

41002

联系人通讯地址
请登录查看
更多信息
获取更多临床信息查看权限
立即前往摩熵医药企业版免费查询
示例数据
<END>

最新临床资讯

摩熵医药企业版
50亿+条医药数据随时查
7天免费试用